Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Construction and Clinical Application of Microfluidic Exosome Chip for Early Diagnosis of Pulmonary Metastasis of Osteosarcoma

NCT05101655 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT05101655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05101655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Construction and Clinical Application of Microfluidic Exosome Chip for Early Diagnosis of Pulmonary Metastasis of Osteosarcoma
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Completed
Start date
October 1, 2020
Completion date
September 30, 2022
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteosarcoma, pulmonary metastases